progression als disease
michael black

als disease
causes progression disease varies

correspond
subsequent

diagnosis diagnosed als
americans living
disease
progression
disease predictors
everything demographics medical lab
outcomes
months clinical trial progression
disease nine months
trial progression disease
als
functional
carry ordinary walking
talking older trials
subjects reasoning
behind disease
progression subjects
procedures

symptoms
clinical physical

shorter survival began
disease onset degeneration motor
neuron lab
descriptions summarized
detailed
forests
reasoning behind variability
forests aim
resampling

benefit
notion comes constructing
sampled
authors
augment
tackling noticed
flexible nonlinear
knew
biggest roadblock achieving
looked
bootstrapping


broke

exact
disease
forests boosted
ordered categorized
progression disease slow
progression disease

settings
confidence
confident
kaggle competition stats
boosted



acquired

acquired
progression disease

havent
prize life pro act
na doctor
collect
threw fraction
recorded
reasoning wasnt

recorded replaced
entries median



clean

causes

decomposed
decreasing
wanted
powerful
penalizing
nonzero penalizing

als disease affects individuals
understood entirely
disease progress
understand
contributed progression
disease association
als
univariate authors
onset diagnosis

exactly
wanted



formulated
coefficient


interpreted budget


irrelevant
contribute budget really

serves
computationally feasible alternative

cv lambda



progression als disease

nonlinear allowed

squares got
narrowed
lambda
lambda
lambda
lambda
narrow
backward
computationally feasible




deal
clustered whereas
fits
rss
accomplished ordering
splits
minimizes
depicted rj

continues handful
leaf piecewise

leaf



prone wanted couple


bootstrapping amounts
resampling replacement
bootstrap replicates sampled



traditional
bootstrapped
job
reducing implementing modifications
traditional
mse
employed
augment
trains
residuals
residuals

summing shrunken sub


learns controlled shrinkage
lambda





categorizing
moderate
slow progression disease

replaced sigmoid multiclass equivalent




wi



posteriori
labelling generative learnt
indicator
nd quantile targets

















optimize
calculates loglikelihood batch
updates

ei

batch


involved

neurons
sigmoid transfer neuron
transfer

validating


implementing
realized separated

involving

threw
belonging middle
separable
splitting
middle
came
maps
infinite thereby
separable
trick dot infinite

artificial


computationally feasible


neurons




reported
held
clinical trials
boosted variants
classical proved
aim
averaging
averaging
bootstrapped boosted
accomplishes
shrunken sub residuals



diminishing
sufficiently ensure
converged lowest mse


root

mse vary neurons


six neurons


mse

inserted mse
reported

boosted
shrinkage interaction
interaction
sub
shrinkage interaction

mse shrinkage


mse

mse shrinkage


varied neurons


mse

reported
detailed




fitable

mse



mse













boosted








reported figures


boundaries

discarded
middle separability







vi
als disease understood
medical clinical trials hope
understand underlying progression
disease diagnose
continue collect continue
prove
beneficial doctors families affected
explained

worked
bootstrapping

mse

confidence
progression
disease
progression
confident

continue gather
modify
explored got
feel worked
worked




selects
depending



acknowledgment
thank pro act prize life
ji park kenneth jung
sharan


fireferences







mm myers
modify susceptibility
progression lateral als lateral

gordon ph cheng pf
progression als
neurology
prize life neurological clinical institute url https partners
hans jung randomforest life
als disease progression
lateral degeneration







leisch hornik
benchmark graphical

james witten hastie tibshirani
springer york isbn


breast diagnosis expert march



